Next Article in Journal
Artificially Expanded Genetic Information Systems for New Aptamer Technologies
Previous Article in Journal
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics

Adiponectin Signaling Pathways in Liver Diseases

Dipartimento di Scienze Biomediche, Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy
Author to whom correspondence should be addressed.
Biomedicines 2018, 6(2), 52;
Received: 26 February 2018 / Revised: 26 April 2018 / Accepted: 2 May 2018 / Published: 7 May 2018
(This article belongs to the Special Issue Adiponectin and Its Receptor Interactions in Human Disease)
In the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitizing effect. The binding of adiponectin with its specific receptors induces the activation of a proper signaling cascade that becomes altered in liver pathologies. This review describes the different signaling pathways in healthy and diseased hepatocytes, also highlighting the beneficial role of adiponectin in autophagy activation and hepatic regeneration. View Full-Text
Keywords: adiponectin; liver; signaling pathway adiponectin; liver; signaling pathway
Show Figures

Figure 1

MDPI and ACS Style

Gamberi, T.; Magherini, F.; Modesti, A.; Fiaschi, T. Adiponectin Signaling Pathways in Liver Diseases. Biomedicines 2018, 6, 52.

AMA Style

Gamberi T, Magherini F, Modesti A, Fiaschi T. Adiponectin Signaling Pathways in Liver Diseases. Biomedicines. 2018; 6(2):52.

Chicago/Turabian Style

Gamberi, Tania, Francesca Magherini, Alessandra Modesti, and Tania Fiaschi. 2018. "Adiponectin Signaling Pathways in Liver Diseases" Biomedicines 6, no. 2: 52.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop